GlassScriptPhysician profile
Bernard W Lee
NPI 1528108404
$1,406.12
in general payments reported to CMS, 2019-2025
13 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $155 · 2024: $241 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797 · Travel and Lodging: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.16 |
| Travel and Lodging | $608.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $608.96 | 2025 | Deep Tms System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $367.19 | 2023-2025 | Xifaxan |
| Exact Sciences Corporation | $111.79 | 2024-2025 | Cologuard Collection Kit |
| Myriad Women'S Health, INC. | $98.46 | 2023 | Myrisk |
| Dexcom, INC. | $35.27 | 2024-2025 | Dexcom G6 Transmitter |
| Fidia Pharma USA INC. | $30.53 | 2024 | Hymovis |
| Aimmune Therapeutics, INC. | $24.78 | 2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $24.23 | 2023 | |
| Lilly USA, LLC | $23.58 | 2024 | Mounjaro, Zepbound |
| Menarini Silicon Biosystems, INC. | $22.16 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.20 | 2024 | Trintellix |
| Amgen INC. | $21.14 | 2024 | Repatha, Otezla |
| Ibsa Pharma INC. | $16.83 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.